Volpara software selected for NHS breast screening project

ASX-listed New Zealand company Volpara Health Technologies has been chosen to provide its VolparaDensity software to a research project being run by the NHS's breast screening program (NHSBSP) in England.

The project is the second stage of the Predicting Risk of Cancer at Screening (PROCAS) study, which aims to improve breast cancer risk prediction for women attending routine breast screening.

Posted in New Zealand eHealth

Tags: Volpara

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2019 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.